The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sharing and reusing of injection equipment, frequency of injections, and years of injection drug use are all known to increase the risk of SSTVI [16–19].”
In the citing paper
“Sharing and reusing of injection equipment, frequency of injections, and years of injection drug use are all known to increase the risk of SSTVI [16–19].”
In the citing paper
“Sharing and reusing of injection equipment, frequency of injections, and years of injection drug use are all known to increase the risk of SSTVI [16–19].”
In the citing paper
“and as 6% within 30 days following discharge in the second and third studies [39,41].”
In the citing paper
“Three administrative linkage cohort studies (all from US insurance claims data) have assessed associations between use of OAT and outcomes after hospitalization with injecting-related bacterial or fungal infections [39–41].”
In the citing paper
“The latter 2 studies also only included information on buprenorphine use, as they did not have access to insurance claims or prescribing records for methadone.”
In the citing paper
“A third identified a reduced risk of rehospitalization for skin and soft-tissue infections at 1 year [41].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Comparative effectiveness of different treatment pathways for opioid use disorder.
Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20622 · Cited by 995
Binswanger, I. A., Kral, A. H., Bluthenthal, R. N., Rybold, D. J., & Edlin, B. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313703 · Cited by 300
Touchpoints—opportunities to predict and prevent opioid overdose: a cohort study.
Larochelle, M. R., Bernstein, R., Bernson, D., Land, T., Stopka, T. J., Rose, A. J., Bharel, M., Liebschutz, J. M., & Walley, A. Y. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.039 · Cited by 189 · cited 1×
“Hospitals may be a pragmatic location to both treat opioid use disorder (OUD) and prevent the associated medical complications (Fanucchi, Walsh, Thornton, Nuzzo, & Lofwall, 2019; LaRochelle et al., 2019).”
Background
Research works printed but not linked: 34
- Alexander, 2018, Trends in black and white opioid mortality in the United States, 1979-2015, Epidemiology, 29, 707, 10.1097/EDE.0000000000000858 · DOI
- Atkins, 2020, Notes from the field: outbreak of human immunodeficiency virus infection among persons who inject drugs - Cabell County, West Virginia, 2018-2019, MMWR Morb. Mortal. Wkly. Rep., 69, 499, 10.15585/mmwr.mm6916a2 · DOI
- Barocas, 2019, Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths, Drug Alcohol Depend., 200, 59, 10.1016/j.drugalcdep.2019.03.014 · DOI
- Barocas, 2020, Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis, Clin. Infect. Dis.
- Burnett, 2018, HIV infection and HIV-associated behaviors among persons who inject drugs - 20 cities, United States, 2015, MMWR Morb. Mortal. Wkly. Rep., 67, 23, 10.15585/mmwr.mm6701a5 · DOI
- Centers for Disease, C., & Prevention, 2011, Vital signs: overdoses of prescription opioid pain relievers---united States, 1999--2008, MMWR Morb. Mortal. Wkly. Rep., 60, 1487
- Ciccarone, 2016, Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions, Drug Alcohol Depend., 163, 126, 10.1016/j.drugalcdep.2016.04.009 · DOI
- Collier, 2018, Using population based hospitalization data to monitor increases in conditions causing morbidity among persons who inject drugs, J. Community Health, 10.1007/s10900-017-0458-9 · DOI
- Cranston, 2019, Notes from the Field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015-2018, MMWR Morb. Mortal. Wkly. Rep., 68, 253, 10.15585/mmwr.mm6810a6 · DOI
- Cunningham, 2006, Attending physicians’ and residents’ attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital, Fam. Med., 38, 336
- Fanucchi, 2019, Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related infections, Clin. Infect. Dis.
- Feder, 2017, Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act, Drug Alcohol Depend., 179, 271, 10.1016/j.drugalcdep.2017.07.015 · DOI · Paper page
- Golden, 2019, Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018, MMWR Morb. Mortal. Wkly. Rep., 68, 344, 10.15585/mmwr.mm6815a2 · DOI
- Gray, 2018, Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study, BMC Infect. Dis., 18, 532, 10.1186/s12879-018-3408-y · DOI
- Hadland, 2018, Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder, JAMA Pediatr., 10.1001/jamapediatrics.2018.2143 · DOI
- Hassamal, 2017, Overcoming barriers to initiating medication-assisted treatment for heroin use disorder in a general medical hospital: a case report and narrative literature review, J. Psychiatr. Pract., 23, 221, 10.1097/PRA.0000000000000231 · DOI
- Lurie, 1998, An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 18, S126, 10.1097/00042560-199802001-00021 · DOI
- Miller, 2018, Many opportunities to record, diagnose, or treat injection drug-related infections are missed: a population-based cohort study of inpatient and emergency department settings, Clin. Infect. Dis.
- Monteiro, 2020, Self-treatment of skin infections by people who inject drugs, Drug Alcohol Depend., 206, 107695, 10.1016/j.drugalcdep.2019.107695 · DOI
- Morgan, 2019, Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort, Drug Alcohol Depend., 200, 34, 10.1016/j.drugalcdep.2019.02.031 · DOI · Paper page
- Njoroge, 2018, Changes in the association of rising infective endocarditis with mortality in people who inject drugs, JAMA Cardiol., 3, 779, 10.1001/jamacardio.2018.1602 · DOI
- Peters, 2016, HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015, N. Engl. J. Med., 375, 229, 10.1056/NEJMoa1515195 · DOI
- Priest, 2020, Opioid agonist therapy during hospitalization within the veterans health administration: a pragmatic retrospective cohort analysis, J. Gen. Intern. Med., 10.1007/s11606-020-05815-0 · DOI · Paper page
- Rapoport, 2018, Infectious diseases physicians’ perspectives regarding injection drug use and related infections, United States, 2017, Open Forum Infect. Dis., 5, 10.1093/ofid/ofy132 · DOI
- Ronan, 2016, Hospitalizations related to opioid Abuse/Dependence and associated serious infections increased sharply, 2002-12, Health Aff. (Millwood), 35, 832, 10.1377/hlthaff.2015.1424 · DOI
- Rosenthal, 2016, Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis, Am. J. Med., 129, 481, 10.1016/j.amjmed.2015.09.024 · DOI · Paper page
- Shah, 2020, Risk factors of infective endocarditis in persons who inject drugs, Harm Reduct. J., 17, 35, 10.1186/s12954-020-00378-z · DOI
- Shanahan, 2010, A transitional opioid program to engage hospitalized drug users, J. Gen. Intern. Med., 25, 803, 10.1007/s11606-010-1311-3 · DOI
- Suzuki, 2016, Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis, Am. J. Addict., 25, 191, 10.1111/ajad.12349 · DOI
- Tan, 2020, Association of hospital discharge against medical advice with readmission and in-hospital mortality, JAMA Netw. Open, 3, e206009, 10.1001/jamanetworkopen.2020.6009 · DOI
- Turner, 2015, Implementing hospital-based baby boomer hepatitis C virus screening and linkage to care: Strategies, results, and costs, J. Hosp. Med., 10, 510, 10.1002/jhm.2376 · DOI
- Walley, 2013, Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis, BMJ, 346, f174, 10.1136/bmj.f174 · DOI · Paper page
- Winetsky, 2018, Expanding treatment opportunities for hospitalized patients with opioid use disorders, J. Hosp. Med., 13, 62, 10.12788/jhm.2861 · DOI
- Zibbell, 2018, Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014, Am. J. Public Health, 108, 175, 10.2105/AJPH.2017.304132 · DOI
Cited by
Sorted by citations
Brothers, T. D., Lewer, D., Jones, N., Colledge-Frisby, S., Farrell, M., Hickman, M., Webster, D., Hayward, A., & Degenhardt, L. (2022) · PLOS Medicine · doi:10.1371/journal.pmed.1004049 · Cited by 25
Zhang, K., Jones, C. M., Compton, W. M., Guy, G. P., Evans, M. E., & Volkow, N. D. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.21m14001 · Cited by 22
Lim, J., Russell, W. A., El-Sheikh, M., Buckeridge, D. L., & Panagiotoglou, D. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01037-3 · Cited by 3
Metadata
- Authors
- Barocas, J. A., Gai, M. J., Amuchi, B., Jawa, R., & Linas, B. P.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 215
- Pages
- 108207
- ISSN
- 0376-8716
- PMC
- PMC7502512
- Cited by
- 34
- References
- 4
- Language
- en
- Funders
- National Institute on Drug Abuse
- Charles A. King Trust
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
